Press release
Global Nontuberculous Mycobacterial Infection Market to Reach $19.57 Billion by 2029, Growing at 6.7% CAGR
Nontuberculous Mycobacterial Infection Market
The surge in occurrences of chronic obstructive pulmonary disease (COPD) is anticipated to boost the nontuberculous mycobacterial infection market's expansion. COPD is a chronic breathing disorder distinguished by consistent and frequently deteriorating lung airflow restriction. Nontuberculous mycobacterial (NTM) infections are noticeable in COPD patients because they lead to a severe decrease in forced expiratory volume in one second (FEV1) and a higher rate of exacerbation. COPD can impair the immune system and harm the lung tissue, rendering it more vulnerable to NTM bacteria. For example, The Scottish Public Health Observatory (ScotPHO) reported in March 2023 that the rates of COPD started to increase from 2021 to 2022. Male rates rose from 83.2 to 97.6 per 100,000 persons, while female rates increased from 72.6 to 97.3. Consequently, the growing occurrence of COPD is fueling the nontuberculous mycobacterial infection market's growth. The Nontuberculous Mycobacterial Infection Market's growth is being driven by the increasing rate of infectious diseases. These illnesses are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals, causing a variety of symptoms and health issues. The escalating occurrence of infectious diseases, including conditions that can lead to NTM infections, could potentially speed up the NTM infection market's growth by raising public consciousness about these infections. This leads to more routine diagnostic tests and early detection, more research and development for NTM treatments, and increased demand for therapies that target NTM pathogens due to an elevated focus on infectious diseases in healthcare. For example, in November 2024, the United Nations International Children's Emergency Fund (UNICEF) reported that pneumonia was the leading infectious disease, causing over 700,000 children's deaths annually or about 2,000 children per day. Therefore, the escalating prevalence of infectious diseases is propelling the nontuberculous mycobacterial infection market's growth.
Get Your Nontuberculous Mycobacterial Infection Market Report Here:
https://www.thebusinessresearchcompany.com/report/nontuberculous-mycobacterial-infection-global-market-report
What Is the projected market size and growth rate for the nontuberculous mycobacterial infection market?
In recent times, there has been substantial growth in the market size for nontuberculous mycobacterial infection. The market, which stood at $14.25 billion in 2024, is projected to reach $15.11 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.0%. This increase observed in the historic period is mainly due to enhanced diagnostic techniques, an aging populace, raised awareness of cystic fibrosis, and the use of immunosuppressive drugs.
Strong expansion is projected in the upcoming years for the nontuberculous mycobacterial infection market, with the expectation to soar to $19.57 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.7%. Driving forces behind this anticipated growth during the forecast period include the development of antimicrobial drugs, enhanced awareness of ntm, advances in the field of genetic research, telehealth, and remote monitoring. Key trends that are likely to shape the forecast period encompass personalized treatments, regulatory emphasis, combined therapies, and digital health instruments.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13020&type=smp
What new trends are reshaping the nontuberculous mycobacterial infection market and its opportunities?
Major corporations that are active in the nontuberculous mycobacterial infection market employ updated treatment approval strategies such as fast track designation for medication approval in order to maintain their market prominence. The Fast Track designation by the FDA is a method aimed at speeding up the review and development of medications for severe conditions that have unfulfilled medical needs. For example, in July 2022, the Food and Drug Administration, an American federal entity, awarded NUZYRA Fast Track Designation for the treatment of nontuberculous mycobacterial (NTM) lung disease resulting from Mycobacterium avium complex (MAC). NUZYRA (omadacycline) is an innovative broad-range antibiotic created to combat severe bacterial infections, inclusive of those induced by resistant strains. This designation enables accelerated development and review for the NUZYRA antibiotic in order to meet substantial unmet medical needs.
What major market segments define the scope and growth of the nontuberculous mycobacterial infection market?
The nontuberculous mycobacterial infection market covered in this report is segmented -
1) By Drug Class: Macrolides, Rifampin, Aminoglycoside, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Other Routes
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Macrolides: Azithromycin, Clarithromycin
2) By Rifampin: Rifampin, Rifabutin
3) By Aminoglycoside: Amikacin, Streptomycin
4) By Other Drug Classes: Ethambutol, Clofazimine, Linezolid
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13020
Which region dominates the nontuberculous mycobacterial infection market?
North America was the largest region in the nontuberculous mycobacterial infection market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in nontuberculous mycobacterial infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which key market leaders are driving the nontuberculous mycobacterial infection industry growth?
Major companies operating in the nontuberculous mycobacterial infection market are Pfizer Inc., Johnson & Johnson, F. Hoffman La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Lupin Limited, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals Inc., Insmed Incorporated, Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Aradigm Corporation, Dauntless Pharmaceuticals Inc., Validus Pharmaceuticals LLC.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13020&type=smp
What Is Covered In The Nontuberculous Mycobacterial Infection Global Market Report?
•Market Size Forecast: Examine the nontuberculous mycobacterial infection market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the nontuberculous mycobacterial infection market for a structured understanding.
•Key Players Overview: Analyze major players in the nontuberculous mycobacterial infection market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the nontuberculous mycobacterial infection market.
•Segment Contributions: Evaluate how different segments drive overall growth in the nontuberculous mycobacterial infection market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the nontuberculous mycobacterial infection market.
•Industry Challenges: Identify potential risks and obstacles affecting the nontuberculous mycobacterial infection market.
•Competitive Landscape: Review strategic developments in the nontuberculous mycobacterial infection market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Nontuberculous Mycobacterial Infection Market to Reach $19.57 Billion by 2029, Growing at 6.7% CAGR here
News-ID: 3914834 • Views: …
More Releases from The Business Research Company
In-Depth Analysis of the Wind Market: Growth Opportunities, Key Trends, and Fore …
What Market Sizedynamics are playing a key role in accelerating the growth of the wind market?
The wind market's expansion is predicted to be driven by a burgeoning demand for renewable energy sources. These renewable power sources, which are replenished naturally over the human timescale without diminishing, are becoming more popular due to environmental considerations, political regulations, and climate objectives. Wind power plays a crucial role in renewable energy plans, offering…
A Deep Dive into Vitamin D Testing Market Size2025: Key Drivers, Growth Factors, …
Which drivers are expected to have the greatest impact on the over the vitamin d testing market's growth?
An increase in awareness about disorders originating from vitamin D deficiency is predicted to fuel the expansion of the vitamin D testing market. A vitamin D deficiency disorder is a health condition that arises when there is not enough vitamin D in the body, influencing calcium absorption adversely and causing problems like fragile…
Rising Neurodegenerative Disorders Fuel Growth In Vinpocetine Market SizeDriver: …
What industry-specific factors are fueling the growth of the vinpocetine market?
The upward trend in neurodegenerative condition cases is anticipated to boost the vinpocetine market's expansion. Neurodegenerative conditions involve a multitude of illnesses marked by the slow decay or death of nerve cells, known as neurons, in the brain or spinal cord. Numerous elements, including the growing elderly populace, unhealthy lifestyle choices, genetic predispositions, and environmental influences contribute to the escalating…
Impact of Rising Pet Ownership On The Growth Of The Veterinary Clinical Trials M …
What combination of drivers is leading to accelerated growth in the veterinary clinical trials market?
The veterinary clinical trials Market Sizeis poised for growth, driven by the increasing population of pet owners. Possessing and caring for one or more pets, referred to as pet ownership, is on the rise due to various reasons. These include the need for company, the therapeutic effects of pets, and enhanced understanding of their positive influence…
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.
Access the PDF sample of the report@…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period.
For More Info, Get Sample Report…
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide…
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986
Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications…
